Price Chart

Profile

TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States. The company's drug candidate includes Envafolimab, TRC102, TRC253, and Bispecific Antibodies.
URL https://www.traconpharma.com
Investor Relations URL http://ir.traconpharma.com/phoenix.zhtml?c=253885&p=irol-irhome
HQ State/Province California
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release Mar. 08, 2024 (est.)
Last Earnings Release May. 10, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States. The company's drug candidate includes Envafolimab, TRC102, TRC253, and Bispecific Antibodies.
URL https://www.traconpharma.com
Investor Relations URL http://ir.traconpharma.com/phoenix.zhtml?c=253885&p=irol-irhome
HQ State/Province California
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Value
Next Earnings Release Mar. 08, 2024 (est.)
Last Earnings Release May. 10, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A